OZONIOTERAPIA COMO TRATAMENTO PARA OSTEORRADIONECROSE
Resumo
Referências
ALDUNATE, J. L. C. B. et al. Osteorradionecrose em face: fisiopatologia, diagnóstico e tratamento. Rev. bras. cir. plást., São Paulo, v. 25, p. 381-387, 2010.
BOCCI, V. et al. The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med. Res. Rev., Estados Unidos, v. 29, p 646-682, 2009.
CÂNCER de boca. Instituto Nacional de Câncer, 2020.
CARDOSO, M. F. A. et al. Prevenção e controle das sequelas bucais em pacientes irradiados por tumores de cabeça e pescoço. Radiol. bras, Rio de Janeiro, v. 38, p. 107-115.
GORAN, B. et al. The use of ozone in the prevention of osteoradionecrosis of the jaw. Saudi Med. J., Arábia Saudita, v.35, p. 1260-1263, 2014.
RAMLI, R. et al. Managing complications of radiation therapy in head and neck cancer patients: Part IV. Management of osteoradionecrosis. Singapore Dent. J., Cingapura, v. 28, p.11-15, 2006.
RIPAMONTI, C. I. et al. Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study. Oral Oncol. Inglaterra, v. 47, p. 185-190, 2011.
SCHWARTZ, A.; MARTÍNEZ-SÁNCHEZ, G. Ozono therapy and its Scientific Foundations. Revista Española de Ozonoterapia, Espanha, v. 2, p. 199-232, 2012.
SPECHT, L. Oral complications in the head and neck radiation patient. Introduction and scope of the problem. Support Care Cancer, Alemanha, v. 10, p. 36-39, 2002.
Apontamentos
- Não há apontamentos.
Direitos autorais 2021 Silmara Terezinha de Andrade Lourenço de Souza, Paulo Roberto Pagano, Thais Bobato Scheifer, Fernanda Alves Pepe